Efficacy of Uronext in chronic recurrent bacterial-viral cystitis with multiple resistance to antibacterial drugs


DOI: https://dx.doi.org/10.18565/urology.2022.2.90-94

Kh.S. Ibishev, Z.K. Gadzhieva, V.K. Mamedov

1) Rostov State Medical University, Rostov-on-Don, Russia; 2) Sechenov First Moscow State Medical Univesity (Sechenov University), Moscow, Russia
Chronic recurrent cystitis (CRC) is one of the most common diseases of the lower urinary tract in the female population. Difficulties in diagnosis and treatment, despite the observance of modern clinical recommendations for CRC, are due to the versatility and polyetiology of the pathogenesis of the disease. The most difficult and discussed section of this problem is the diagnosis and treatment of CRC of papillomavirus (PV) etiology.
The article presents its own clinical observation - Diagnosis and treatment of a patient with CRC PV etiology.
CRC, in addition to bacterial uropathogens, can be caused by various representatives of a viral infection. Among all viral pathogens, HPV has the widest pathogenic potential.
Currently, there is no single etiotropic therapy for PVI of the urinary tract and reproductive organs; there is no systemic treatment of patients with HPV-associated lesions, including the bladder. Nevertheless, an important principle of therapy, which has already become an axiom, is applied - an integrated approach that includes anti-inflammatory,antiadhesive, antiviral and immunoactive therapy

About the Autors


Corresponding author: Kh.S. Ibishev - PhD in Medical Sciences, Professor of Department of Urology and Human Reproductive Health with a course in Pediatric Urology-Andrology, Rostov state medical university, Rostov-on-don, Russia; e-mail: ibishev22@mail.ru


Similar Articles


Бионика Медиа